Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 4 Thoracic 2 Gynecologic 2 Sarcoma 1 Other solid neoplasm 1 Genitourinary 1 CNS 1

Conditions

Interventions

Cyclophosphamide 54 Specimen Handling 50 Magnetic Resonance Spectroscopy 49 pembrolizumab 43 Doxorubicin 43 Radiotherapy 42 Temozolomide 37 Biopsy 34 Radiation 29 Nivolumab 28 fludarabine 23 Vincristine 22 Irinotecan 21 Gemcitabine 21 X-Rays 20 Surgical Procedures, Operative 19 Ifosfamide 19 atezolizumab 17 cabozantinib 15 Ipilimumab 15 olaparib 13 Sunitinib 13 Paclitaxel 13 regorafenib 12 fludarabine phosphate 12 Phantoms, Imaging 12 Imatinib Mesylate 12 Etoposide 12 Blood Specimen Collection 12 Carboplatin 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

fluzoparib × Sarcoma × 1 year × Clear all

NCT05938374 2025-12-11

SPARE-03

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Completed

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡